Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Fradet

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Should Canadians be offered systematic prostate cancer screening? YesYves Fradet
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Rebuttal: Should Canadians be offered systematic prostate cancer screening? YESYves Fradet
The Journal of Urology|March 20, 2012
Cost-effectiveness of fluorescent cystoscopy for noninvasive papillary tumors: proYves Fradet
The Canadian Journal of Urology|May 9, 2003
Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade markYves Fradet, Campbell Lockhard
Current Opinion in Urology|April 16, 2002
New diagnostic and prognostic tools in bladder cancerRabi Tiguert, Yves Fradet
The Canadian Journal of Urology|April 5, 2001
Blood management and radical retropubic prostatectomy: Quebec experienceLouis Lacombe, Yves Fradet
Current Opinion in Urology|August 2, 2008
The detection of genetic markers of bladder cancer in urine and serumMichele Lodde, Yves Fradet
The Canadian Journal of Urology|July 18, 2002
Controversies in the management of localized prostate cancer: consensus development by Canadian urologistsLaurence H Klotz, Yves Fradet
Urologic Oncology|December 12, 2002
Identification of two genes differentially expressed upon different spatial configuration of the MGH-U3 human bladder cancer cellsSerge Champetier, Yves Fradet, Dimcho Bachvarov
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 23, 2003
[Molecular markers of infiltrating cancer of the bladder]Jérôme Rigaud, Rabi Tiguert, Yves Fradet
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Should Canadians be offered systematic prostate cancer screening? YesYves Fradet
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Rebuttal: Should Canadians be offered systematic prostate cancer screening? YESYves Fradet
The Journal of Urology|March 20, 2012
Cost-effectiveness of fluorescent cystoscopy for noninvasive papillary tumors: proYves Fradet
The Canadian Journal of Urology|May 9, 2003
Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade markYves Fradet, Campbell Lockhard
Current Opinion in Urology|April 16, 2002
New diagnostic and prognostic tools in bladder cancerRabi Tiguert, Yves Fradet
The Canadian Journal of Urology|April 5, 2001
Blood management and radical retropubic prostatectomy: Quebec experienceLouis Lacombe, Yves Fradet
Current Opinion in Urology|August 2, 2008
The detection of genetic markers of bladder cancer in urine and serumMichele Lodde, Yves Fradet
The Canadian Journal of Urology|July 18, 2002
Controversies in the management of localized prostate cancer: consensus development by Canadian urologistsLaurence H Klotz, Yves Fradet
Urologic Oncology|December 12, 2002
Identification of two genes differentially expressed upon different spatial configuration of the MGH-U3 human bladder cancer cellsSerge Champetier, Yves Fradet, Dimcho Bachvarov
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 23, 2003
[Molecular markers of infiltrating cancer of the bladder]Jérôme Rigaud, Rabi Tiguert, Yves Fradet
Pageof 24